APPLICATION
NDA017108
TYPE
NDA
ORIGINAL APPROVAL
1973-03-14
LATEST ACTION
1979-12-12
ROUTE
ORAL
DOSAGE FORM
TABLET, EFFERVESCENT, TABLET, DISPERSIBLE
MARKETING STATUS
Discontinued
Products
WESTADONEDiscontinued
METHADONE HYDROCHLORIDE 10MG · TABLET, EFFERVESCENT · ORAL
WESTADONEDiscontinued
METHADONE HYDROCHLORIDE 2.5MG · TABLET, DISPERSIBLE · ORAL
WESTADONEDiscontinued
METHADONE HYDROCHLORIDE 40MG · TABLET, EFFERVESCENT · ORAL
WESTADONEDiscontinued
METHADONE HYDROCHLORIDE 5MG · TABLET, EFFERVESCENT · ORAL
Approval history
1979-12-12Labeling · Supplement 8AP
1977-06-03Labeling · Supplement 7AP
1977-04-25Labeling · Supplement 5AP
1976-09-07Labeling · Supplement 3AP
1973-03-14Type 3 - New Dosage Form · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.